David Brooks - January 28, 2025 Battery Report 2024: At sea and in space – EVs beyond cars The Volta Foundation have just released the 2024 edition of their annual Battery Report. These ...
Adam Gregory - July 15, 2024 Mewburn Ellis is proud to have worked on 26 of the 100 top-selling pharmaceuticals of 2023 Mewburn Ellis is proud to work with some of the world’s most globally significant pharmaceuticals, ...
David Brooks - February 27, 2024 Graphene Medtech: The Next Frontier It has been 20 years since Andre Geim and Konstantin Novoselov first isolated graphene: the two ...
David Brooks - December 20, 2023 UK Battery Strategy Commentary Ahead of the Global Investment Summit hosted recently in November 2023 at Hampton Court Palace, the ...
David Brooks - December 5, 2023 Layering up: how graphene is disrupting the sportswear industry Earlier this year, Novak Djokovic broke the men’s tennis record for the most Grand Slam tournament ...
David Brooks - September 6, 2023 Graphene: permeating the hydrogen economy The growth of the so-called “hydrogen economy” is crucial to achieving net-zero carbon emissions ...
David Brooks - September 6, 2023 IP audits for battery and energy storage businesses Companies working in the fields of batteries and energy storage often have a wealth of intellectual ...
David Brooks - July 19, 2023 Mewburn Ellis is proud to work on 18 of the 50 top-selling pharmaceuticals of 2022 Last year we reported the unprecedented growth of the innovative pharmaceuticals industry in 2021 ...
David Brooks - November 24, 2022 Graphene: the commercial disrupter Graphene has generated a tremendous amount of excitement since it was first isolated at the ...
Adam Gregory - July 22, 2022 Mewburn Ellis is proud to work on 19 of the 50 top-selling pharmaceuticals of 2021 2021 was a year of unprecedented success for the biotech and pharmaceutical industries, with the ...
